gemfibrozil cost-benefit model
Read Online

gemfibrozil cost-benefit model analysis of data from the Helsinki Heart Study, model development, and extension to the California Medicaid population by Syam Sarma

  • 355 Want to read
  • ·
  • 85 Currently reading

Published by RAND in Santa Monica, CA (1700 Main St., P.O. Box 2138, Santa Monica 90407-2138) .
Written in English


  • Cost-Benefit Analysis -- economics -- United States -- statistics.,
  • Gemfibrozil -- therapeutic use.,
  • Hyperlipidemia -- drug therapy.,
  • Coronary Disease -- economics -- United States -- statistics.,
  • Medicaid -- economics -- California -- statistics.,
  • Coronary heart disease -- Treatment.,
  • Coronary heart disease -- Prevention -- Finland.,
  • Digoxin.,
  • Medicaid -- California.

Book details:

Edition Notes

StatementSyam Sarma.
SeriesDissertation, Dissertation (Rand Graduate School)
ContributionsRand Graduate School.
The Physical Object
Paginationix, 139 p. :
Number of Pages139
ID Numbers
Open LibraryOL16600857M

Download gemfibrozil cost-benefit model


R.C.L. Page, in Side Effects of Drugs Annual, Drug–drug interactions Gemfibrozil. Gemfibrozil increases the blood glucose-lowering effect of repaglinide. The timing of the last dose of gemfibrozil has been studied in 10 healthy volunteers who took repaglinide mg without gemfibrozil and then again 0, 3, 6, or 12 hours after gemfibrozil mg [70 c]. Gemfibrozil, but not fenofibrate, adversely affects the pharmacokinetics of most statins.A summary of the effects of the fibrates on statin blood concentrations is listed in Table Several mechanisms for this interaction appear to contribute. Like cyclosporine, gemfibrozil interferes with OATP1B1-mediated transport of the statin into the hepatocyte, which could lead to an . Title(s): The gemfibrozil cost-benefit model: analysis of data from the Helsinki Heart Study, model development, and extension to the California Medicaid population/ Syam Sarma. Country of Publication: United States Publisher: Santa Monica, CA ( Main St., P.O. Box , Santa Monica ): RAND, For regulatory purposes in cost-benefit analyses of environmental issues, the Environmental Protection Agency (EPA) sets the value of a statistical life-year at $, The EPA estimate is based on an estimate of $ million in dollars (17) for 1 statistical life that was calculated using wage differentials for risky jobs in the labor Author: Thomas J. Hoerger, John S. Wittenborn, Walter Young.

A Cost-Benefit Analysis of Lipid Standardization in the United States Article (PDF Available) in Preventing chronic disease 8(6):A November with Reads How we measure 'reads'. Adsorption has become a competitive method in the field of wastewater and air treatment. Adsorption kinetics is one of the main factors that must be understood before the applicability of any adsorbent. In every adsorption process, linear or non-linear analysis of the kinetics is applied. The goodness of fit index (coefficient of correlation or sum of squares) is applied to access the best by: 5. A pharmacist is presenting the Helsinki trial which investigated gemfibrozil 1, mg daily versus control. The results showed that CHD events were % in the gemfibrozil arm versus % in the control group, with a p-value of. A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text.

  What to do about High Cholesterol. Dear Reader, The buzz about high cholesterol has faded to a low hum in as other health topics grab the headlines. In the recent past years, micropollutants that are pharmaceutically active compounds (PhACs) have been used extensively and have been discovered in raw sewage, wastewater treatment plants, effluents, surface, and groundwater with concentrations from ng/L to several μg/L. Even though many of these compounds are still not determined online, monitoring technology Author: Berna Kırıl Mert, Nihan Ozengin, Esra Can Dogan, CoskunAydıner. IRON; Iron is an essential mineral required for the regulation of cell growth and differentiation, as well as a component of oxygen transport. Patients with irondeficiency will develop microcytic-hypochromic anemia and have red blood cells that are small in size, pale, and low in hemoglobin. Iron-deficiency anemia (IDA) reduces the oxygen-carrying capacity of the blood, leading to . CURRICULUM VITAE CHRISTOPHER J. DESTACHE PERSONAL Home: South Avenue Circle Omaha, Nebraska () Office: Creighton University School of Pharmacy and Health Professions Department of Pharmacy Practice Omaha, Nebraska () [email protected] Size: KB.